Isoferulic acid alleviates LPS/D-galactosamine-induced acute liver injury in mice by inhibiting ERK/NF-κB signaling and modulating the NLRP3 inflammasome
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05684-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Fu-Chao Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Chemical and Drug Induced Liver Injury, Inflammasomes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Chang Gung Memorial Hospital, Linkou.
Abstract (Originalsprache)
Isoferulic acid, a bioactive constituent derived from Cimicifuga species, is structurally related to ferulic acid, a compound known for its hepatoprotective properties. Despite this similarity, its potential role in acute liver injury and the associated molecular mechanisms have not been fully clarified. In the present study, we investigated the protective effects of isoferulic acid in a murine model of acute liver injury induced by lipopolysaccharide (LPS) and D-galactosamine (D-GalN). Isoferulic acid (10, 30, or 60 mg/kg) was administered after LPS/D-GalN challenge. Treatment markedly alleviated liver injury, as reflected by a dose-dependent decrease in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST)levels, along with improvement in histopathological features. Isoferulic acid also reduced oxidative stress in hepatic tissue, evidenced by lower malondialdehyde (MDA) levels, and attenuated the production of pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and interferon (IFN)-γ. Further analysis indicated that these protective effects were associated with suppression of extracellular signal-regulated kinase (ERK) phosphorylation and inhibition of nuclear factor-kappa B (NF-κB) nuclear translocation, suggesting modulation of key inflammatory signaling pathways. In addition, isoferulic acid reduced NLRP3 expression and IL-1β production, suggesting modulation of NLRP3 inflammasome-associated responses. Collectively, these findings indicate that isoferulic acid protects against LPS/D-GalN-induced acute liver injury by reducing oxidative stress and inhibiting ERK/NF-κB and modulating NLRP3 inflammasome-associated responses. Isoferulic acid may represent a potential therapeutic candidate for acute liver failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Chinese Acupuncture and Traumatology, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan. m7079@cgmh.org.tw.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan. m7079@cgmh.org.tw.
ORCID-Profile: Hung-Chen Lee
Förderung
- Ministry of Science and Technology, Taiwan
- Chang Gung Memorial Hospital, Linkou
Zitieren
APA
Liu, F. C., Yang, Y. H., Liao, C. C., & Lee, H. C. (2026). Isoferulic acid alleviates LPS/D-galactosamine-induced acute liver injury in mice by inhibiting ERK/NF-κB signaling and modulating the NLRP3 inflammasome. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05684-0
Vancouver
Liu FC, Yang YH, Liao CC, Lee HC. Isoferulic acid alleviates LPS/D-galactosamine-induced acute liver injury in mice by inhibiting ERK/NF-κB signaling and modulating the NLRP3 inflammasome. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05684-0
BibTeX
@article{Liu2026,
author = {Liu, Fu-Chao and Yang, Yuan-Han and Liao, Chia-Chih and Lee, Hung-Chen},
title = {Isoferulic acid alleviates LPS/D-galactosamine-induced acute liver injury in mice by inhibiting ERK/NF-κB signaling and modulating the NLRP3 inflammasome},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05684-0}
}
EUVIMED